These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 33031817)
1. Trace Amine-Associated Receptor 1 (TAAR1): A new drug target for psychiatry? Dodd S; F Carvalho A; Puri BK; Maes M; Bortolasci CC; Morris G; Berk M Neurosci Biobehav Rev; 2021 Jan; 120():537-541. PubMed ID: 33031817 [TBL] [Abstract][Full Text] [Related]
2. Binding of SEP-363856 within TAAR1 and the 5HT Nair PC; Miners JO; McKinnon RA; Langmead CJ; Gregory KJ; Copolov D; Chan SKW; Bastiampillai T Mol Psychiatry; 2022 Jan; 27(1):88-94. PubMed ID: 34376825 [TBL] [Abstract][Full Text] [Related]
3. TAAR1 as an emerging target for the treatment of psychiatric disorders. Liu J; Wu R; Li JX Pharmacol Ther; 2024 Jan; 253():108580. PubMed ID: 38142862 [TBL] [Abstract][Full Text] [Related]
4. Recognition of methamphetamine and other amines by trace amine receptor TAAR1. Liu H; Zheng Y; Wang Y; Wang Y; He X; Xu P; Huang S; Yuan Q; Zhang X; Wang L; Jiang K; Chen H; Li Z; Liu W; Wang S; Xu HE; Xu F Nature; 2023 Dec; 624(7992):663-671. PubMed ID: 37935377 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies. Dedic N; Dworak H; Zeni C; Rutigliano G; Howes OD Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947997 [TBL] [Abstract][Full Text] [Related]
6. [Research progress on the immunomodulatory effects and mechanisms of trace amine-associated receptor 1]. Zhang XQ; Li JT; Si TM; Su YA Sheng Li Xue Bao; 2023 Apr; 75(2):248-254. PubMed ID: 37089099 [TBL] [Abstract][Full Text] [Related]
10. TAARs as Novel Therapeutic Targets for the Treatment of Depression: A Narrative Review of the Interconnection with Monoamines and Adult Neurogenesis. Shemiakova TS; Efimova EV; Gainetdinov RR Biomedicines; 2024 Jun; 12(6):. PubMed ID: 38927470 [TBL] [Abstract][Full Text] [Related]
11. Trace amine-associated receptor 1 (TAAR1) agonism as a new treatment strategy for schizophrenia and related disorders. Halff EF; Rutigliano G; Garcia-Hidalgo A; Howes OD Trends Neurosci; 2023 Jan; 46(1):60-74. PubMed ID: 36369028 [TBL] [Abstract][Full Text] [Related]
12. Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use Disorders. Wu R; Li JX CNS Drugs; 2021 Dec; 35(12):1239-1248. PubMed ID: 34766253 [TBL] [Abstract][Full Text] [Related]
14. [Research progress of trace amine-associated receptor 1 signaling pathways]. Sun M; Zhang CC; Li JT; Si TM; Su YA Sheng Li Xue Bao; 2024 Feb; 76(1):89-96. PubMed ID: 38444134 [TBL] [Abstract][Full Text] [Related]
15. Ligand recognition and G-protein coupling of trace amine receptor TAAR1. Xu Z; Guo L; Yu J; Shen S; Wu C; Zhang W; Zhao C; Deng Y; Tian X; Feng Y; Hou H; Su L; Wang H; Guo S; Wang H; Wang K; Chen P; Zhao J; Zhang X; Yong X; Cheng L; Liu L; Yang S; Yang F; Wang X; Yu X; Xu Y; Sun JP; Yan W; Shao Z Nature; 2023 Dec; 624(7992):672-681. PubMed ID: 37935376 [TBL] [Abstract][Full Text] [Related]
16. In Vitro Comparison of Ulotaront (SEP-363856) and Ralmitaront (RO6889450): Two TAAR1 Agonist Candidate Antipsychotics. Ågren R; Betari N; Saarinen M; Zeberg H; Svenningsson P; Sahlholm K Int J Neuropsychopharmacol; 2023 Sep; 26(9):599-606. PubMed ID: 37549917 [TBL] [Abstract][Full Text] [Related]